Flora Growth Corp
FLGC
Get informed when a big investor buys or sells
+ FollowMarket Cap$77.6K
Close$
Share Statistics
| Market cap | $77,596.00 |
|---|---|
| Enterprise Value | $4.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.9 |
| Outstanding Shares | 9,961 |
Return
| Return on Equity | -183.49% |
|---|---|
| Return on Assets | -100.66% |
| Return on Invested Capital | -184.61% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0 |
| Price to Sales | -0.02 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | -1.18 |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.59 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 23, 2026
EPS Estimate
$-1.97
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.23%▼ 0.92% |
|---|---|
| Total Invested | $8,000▼ 92.66% |
| Investors Holding | 7▼ 4.00% |
ESG Score
No data
About Flora Growth Corp
21 employees
CEO: Daniel Reis-Faria ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceuti...